May 15 (Reuters)-
Daiken Medical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 9.95 9.75 10.50 5.12
(+2.1 pct) (+6.7 pct) (+5.5 pct) (+4.2 pct)
Operating 1.51 1.44 1.01 460 mln
(+4.8 pct) (+36.8 pct) (-33.2 pct) (-45.0 pct)
Recurring 1.51 1.45 1.00 455 mln
(+4.1 pct) (+37.6 pct) (-33.8 pct) (-45.6 pct)
Net 1.10 988 mln 700 mln 320 mln
(+11.0 pct) (+38.8 pct) (-36.2 pct) (-47.4 pct)
EPS 38.21 yen 34.41 yen 24.37 yen 11.14 yen
Ann Div 23.00 yen 21.00 yen 20.00 yen
-Q2 Div 9.00 yen 9.00 yen 9.00 yen
-Q4 Div 14.00 yen 12.00 yen 11.00 yen
NOTE - Daiken Medical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7775.T